Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 7 of 7

Publication Record


Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation.
Ritchie MD, Rowan S, Kucera G, Stubblefield T, Blair M, Carter S, Roden DM, Darbar D
(2012) J Am Coll Cardiol 60: 1173-81
MeSH Terms: Adult, Aged, Atrial Fibrillation, Atrial Natriuretic Factor, Chromosomes, Human, Pair 4, Cohort Studies, Genetic Predisposition to Disease, Genotype, Homeobox Protein Nkx-2.5, Homeodomain Proteins, Humans, Ion Channels, KCNQ1 Potassium Channel, Kv1.5 Potassium Channel, Middle Aged, Mutation, NAV1.5 Voltage-Gated Sodium Channel, Pedigree, Polymorphism, Single Nucleotide, Prospective Studies, Registries, Transcription Factors
Show Abstract · Added June 26, 2014
OBJECTIVES - The aim of this study was to test the hypothesis that 2 common polymorphisms in the chromosome 4q25 region that have been associated with atrial fibrillation (AF) contribute to the variable penetrance of familial AF.
BACKGROUND - Although mutations in ion channels, gap junction proteins, and signaling molecules have been described for Mendelian forms of AF, penetrance is highly variable. Recent studies have consistently identified 2 common single-nucleotide polymorphisms in the chromosome 4q25 region as independent AF susceptibility alleles.
METHODS - Eleven families in which AF was present in ≥2 members who also shared a candidate gene mutation were studied. These mutations were identified in all subjects with familial lone AF (n = 33) as well as apparently unaffected family members (age >50 years with no AF; n = 17).
RESULTS - Mutations were identified in SCN5A (n = 6), NPPA (n = 2), KCNQ1 (n = 1), KCNA5 (n = 1), and NKX2.5 (n = 1). In genetic association analyses, unstratified and stratified according to age of onset of AF and unaffected age >50 years, there was a highly statistically significant association between the presence of both common (rs2200733 and rs10033464) and rare variants and AF (unstratified p = 1 × 10(-8), stratified [age of onset <50 years and unaffected age >50 years] p = 7.6 × 10(-5)) (unstratified p < 0.0001, stratified [age of onset <50 years and unaffected age >50 years] p < 0.0001). Genetic association analyses showed that the presence of common 4q25 risk alleles predicted whether carriers of rare mutations developed AF (p = 2.2 × 10(-4)).
CONCLUSIONS - Common AF-associated 4q25 polymorphisms modify the clinical expression of latent cardiac ion channel and signaling molecule gene mutations associated with familial AF. These findings support the idea that the genetic architecture of AF is complex and includes both rare and common genetic variants.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
0 Communities
1 Members
0 Resources
22 MeSH Terms
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.
Yang T, McBride BF, Leake BF, Kim RB, Roden DM
(2010) Br J Pharmacol 161: 1023-33
MeSH Terms: ATP Binding Cassette Transporter, Subfamily B, ATP Binding Cassette Transporter, Subfamily B, Member 1, Animals, Anti-Arrhythmia Agents, Binding Sites, Biological Transport, CHO Cells, Cell Line, Cricetinae, Cricetulus, Gene Expression Regulation, Humans, Kv1.5 Potassium Channel, Organic Cation Transport Proteins, Protein Binding, Swine
Show Abstract · Added March 7, 2014
BACKGROUND AND PURPOSE - A common site for drug binding on voltage-gated ion channels is at the interior face of the channel pore. In this study, we tested the hypothesis that the extent of drug block of the human cardiac KCNA5 (K(v) 1.5) channel underlying the atrial-specific, ultra-rapidly activating, delayed K(+) current (I(Kur) ) is modulated by the drug uptake and efflux transporters encoded by organic cation transporter 1 (OCTN1) and multiple drug-resistant gene 1 (MDR1) and expressed in human heart.
EXPERIMENTAL APPROACH - Drug block of KCNA5 was assessed in Chinese hamster ovary cells transiently transfected with KCNA5 alone or in combination with the OCTN1 or MDR1 transporter construct, as well as in an MDR1 stably expressed cell line.
KEY RESULTS - Co-expression of OCTN1 significantly facilitated block by quinidine (10 µM), verapamil (20 µM), propafenone (5 µM) and clofilium (30 µM). Further evidence of drug transport modulating drug block was the finding that with OCTN1, block developed faster and only partially washed-out, and that block potentiation was prevented by cimetidine, an inhibitor of OCTN1. MDR1 expression attenuated KCNA5 block by erythromycin (an MDR1 substrate). Block was restored by reversin-205 (10 µM, an MDR1 inhibitor). MDR1 did not affect KCNA5 inhibition by KN-93 (1 µM), a blocker acting on the outer mouth of the channel pore.
CONCLUSIONS AND IMPLICATIONS - The extent of drug block of KCNA5 can be modulated by drug uptake and efflux transporters. These data provide further support for the idea that modifying intracellular drug concentrations could modulate the effects of blocking ion channels in patients.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.
1 Communities
2 Members
2 Resources
16 MeSH Terms
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation.
Yang T, Yang P, Roden DM, Darbar D
(2010) Heart Rhythm 7: 1246-52
MeSH Terms: Adolescent, Adult, Atrial Fibrillation, DNA, Electrocardiography, Female, Follow-Up Studies, Genetic Predisposition to Disease, Humans, Kv1.5 Potassium Channel, Male, Mutation, Patch-Clamp Techniques, Pedigree, Polymerase Chain Reaction, Prospective Studies, Protein-Tyrosine Kinases, Signal Transduction, Young Adult
Show Abstract · Added March 7, 2014
BACKGROUND - Emerging evidence has strongly implicated hereditary determinants for atrial fibrillation (AF). Loss-of-function mutations in KCNA5 encoding the ultrarapid delayed rectifier potassium current I(Kur) have been identified in AF families.
OBJECTIVE - The purpose of this study was to determine the clinical and biophysical phenotypes in a KCNA5 mutation with deletion of 11 amino acids in the N-terminus of the protein, which was identified in patients with lone AF.
METHODS - Patients with AF confirmed by ECG were prospectively enrolled in the Vanderbilt AF Registry, which comprises clinical and genetic databases. A KCNA5 mutation was generated by mutagenesis for electrophysiologic characterization.
RESULTS - We identified a novel 33-bp coding region deletion in two Caucasian probands. One proband was part of a kindred that included four other members with AF, and all were mutation carriers. The mutation results in deletion of 11 amino acids in the N-terminus of the protein, a proline-rich region as a binding site for Src homology 3 (SH3) domains associated with Src-family protein tyrosine kinase (TK) pathway. In transfected cells, the mutant caused approximately 60% decreased I(Kur) versus wild-type (WT) (75 +/- 8 pA/pF vs 180 +/- 15 pA/pF, P <.01) and dominant-negative effect on WT current (105 +/- 10 pA/pF, P <.01). Pretreatment with the Src inhibitor PP2 prevented v-Src TK from 90% suppressed WT current. In contrast, the mutant channel displayed no response to v-Src TK.
CONCLUSION - Our data implicate abnormal atrial repolarization control due to variable TK signaling as a mechanism in familial AF and thereby suggest a role for modulation of this pathway in AF and its treatment.
Copyright 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
0 Communities
1 Members
0 Resources
19 MeSH Terms
Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
Yang Z, Browning CF, Hallaq H, Yermalitskaya L, Esker J, Hall MR, Link AJ, Ham AJ, McGrath MJ, Mitchell CA, Murray KT
(2008) Cardiovasc Res 78: 449-57
MeSH Terms: Animals, Atrial Function, CHO Cells, Cricetinae, Cricetulus, Heart Atria, Humans, Immunoprecipitation, Intracellular Signaling Peptides and Proteins, Kv1.5 Potassium Channel, LIM Domain Proteins, Mass Spectrometry, Membrane Potentials, Microscopy, Confocal, Muscle Proteins, Myocytes, Cardiac, Potassium, Protein Binding, Recombinant Fusion Proteins, Time Factors, Transfection
Show Abstract · Added April 18, 2013
AIMS - Protein-protein interactions are critical for the normal membrane trafficking, localization, and function of voltage-gated ion channels. In human heart, the Shaker-related voltage-gated K(+) channel KCNA5 alpha-subunit forms the major basis of an atrial-specific, ultra-rapid delayed rectifier K(+) current, I(Kur). We sought to identify proteins that interact with KCNA5 in human atrium and investigate their role in the I(Kur) complex.
METHODS AND RESULTS - Using a glutathione-S-transferase (GST)-KCNA5 C-terminal fusion protein and mass spectrometry-based methods, the scaffolding protein four and a half LIM (for Lin-11, Isl-1, and Mec3) protein 1 (FHL1) was identified as a potential protein partner for KCNA5. Immunoprecipitation experiments confirmed a physical interaction of FHL1 with the K(+) channel complex in human atrium, as well as in Chinese hamster ovary (CHO) cells transfected with both KCNA5 and FHL1. In cotransfected cells, confocal microscopy demonstrated areas of colocalization after immunolabelling both proteins. To investigate the functional effects of this interaction, K(+) currents were recorded in CHO cells transfected with KCNA5 in the absence and presence of FHL1 coexpression. With coexpression of FHL1, K(+) current density was markedly increased, compared with cells expressing KCNA5 alone. This effect was associated with a shift in the voltage dependence of K(+) channel activation to more positive potentials, consistent with findings of I(Kur) in atrial myocytes. FHL1 also increased the extent and speed of K(+) current slow inactivation, with additional effects on the voltage dependence and recovery of this process.
CONCLUSION - These results support a role of FHL1 as a key molecular component in the I(Kur) complex in human atrium, where it likely regulates functional expression of KCNA5.
0 Communities
2 Members
0 Resources
21 MeSH Terms
Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit.
Williams CP, Hu N, Shen W, Mashburn AB, Murray KT
(2002) J Pharmacol Exp Ther 302: 545-50
MeSH Terms: Enzyme Activation, Humans, Kinetics, Kv1.2 Potassium Channel, Kv1.5 Potassium Channel, Phosphorylation, Potassium Channels, Potassium Channels, Voltage-Gated, Protein Kinase C, Protein Subunits, Tetradecanoylphorbol Acetate
Show Abstract · Added January 20, 2015
Kv1.5 is the principal molecular component of I(Kur), an atrial-specific K(+) current in human myocytes that is suppressed by activation of protein kinase C (PKC). We examined the effect of phorbol 12-myristate 13-acetate (PMA), a direct activator of PKC, on Kv1.5 current. Although PMA had minimal effect when Kv1.5 was expressed alone, K(+) currents derived from coexpression of Kvbeta1.2 (but not another closely related beta subunit, Kvbeta1.3) with Kv1.5 were markedly reduced by PMA, associated with a small depolarizing shift in the voltage dependence of channel activation. Additional experiments with an inactive stereoisomer, 4alpha-PMA, and the PKC inhibitor chelerythrine indicated that the effects of PMA were mediated by PKC activation. Assembly of Kv1.5 in vivo with both beta subunits was demonstrated, and all three K(+) channel proteins were substrates for phosphorylation by PKC. These results demonstrate that coexpression of Kvbeta1.2 enhances the response of Kv1.5 to PKC activation and that direct phosphorylation of K(+) channel subunits is a potential molecular basis for the effect. Furthermore, they suggest that Kvbeta1.2 may be a component of the I(Kur) complex in human atrium.
0 Communities
1 Members
0 Resources
11 MeSH Terms
Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
Yang IC, Scherz MW, Bahinski A, Bennett PB, Murray KT
(2000) J Pharmacol Exp Ther 294: 955-62
MeSH Terms: Animals, CHO Cells, Chromans, Cricetinae, Humans, Ion Channel Gating, KCNQ Potassium Channels, KCNQ1 Potassium Channel, Kv1.5 Potassium Channel, Patch-Clamp Techniques, Potassium Channel Blockers, Potassium Channels, Potassium Channels, Voltage-Gated, Recombinant Proteins, Shal Potassium Channels, Stereoisomerism, Sulfonamides
Show Abstract · Added January 20, 2015
Selective inhibitors of the slow component of the cardiac delayed rectifier K(+) current, I(Ks), are of interest as novel class III antiarrhythmic agents and as tools for studying the physiologic roles of the I(Ks) current. Racemic chromanol 293B is an inhibitor of both native I(Ks) and its putative molecular counterpart, the KvLQT1+minK ion channel complex. We synthesized the (+)-[3S,4R] and (-)-[3R,4S] enantiomers of chromanol 293B using chiral intermediates of known absolute configuration and determined their relative potency to block recombinant human K(+) channels that form the basis for the major repolarizing K(+) currents in human heart, including KvLQT1+minK, human ether-a-go-go-related gene product (hERG), Kv1.5, and Kv4.3, corresponding to the slow (I(Ks)), rapid (I(Kr)), and ultrarapid (I(Kur)) delayed rectifier currents and the transient outward current (I(To)), respectively. K(+) channels were expressed in mammalian cells and currents were recorded using the whole-cell patch-clamp technique. We found that the physicochemical properties and relative potency of the enantiomers differed from those reported previously, with (-)-[3R,4S]293B nearly 7-fold more potent in block of KvLQT1+minK than (+)-[3S,4R]293B, indicating that the original stereochemical assignments were reversed. K(+) current inhibition by (-)-293B was selective for KvLQT1+minK over hERG, whereas the stereospecificity of block for KvLQT1+minK and Kv1.5 was preserved, with (-)-293B more potent than (+)-293B for both channel complexes. We conclude that the (-)-[3R,4S] enantiomer of chromanol 293B is a selective inhibitor of KvLQT1+minK and therefore a useful tool for studying I(Ks).
0 Communities
1 Members
0 Resources
17 MeSH Terms
Protein kinase A phosphorylation alters Kvbeta1.3 subunit-mediated inactivation of the Kv1.5 potassium channel.
Kwak YG, Hu N, Wei J, George AL, Grobaski TD, Tamkun MM, Murray KT
(1999) J Biol Chem 274: 13928-32
MeSH Terms: Amino Acid Substitution, Animals, Cell Line, Consensus Sequence, Cyclic AMP-Dependent Protein Kinases, Enzyme Activation, Humans, Kv1.3 Potassium Channel, Kv1.5 Potassium Channel, Mutagenesis, Site-Directed, Oocytes, Phosphorylation, Potassium Channels, Potassium Channels, Voltage-Gated, Serine, Structure-Activity Relationship, Xenopus laevis
Show Abstract · Added January 20, 2015
The human Kv1.5 potassium channel forms the IKur current in atrial myocytes and is functionally altered by coexpression with Kvbeta subunits. To explore the role of protein kinase A (PKA) phosphorylation in beta-subunit function, we examined the effect of PKA stimulation on Kv1.5 current following coexpression with either Kvbeta1.2 or Kvbeta1.3, both of which coassemble with Kv1.5 and induce fast inactivation. In Xenopus oocytes expressing Kv1.5 and Kvbeta1.3, activation of PKA reduced macroscopic inactivation with an increase in K+ current. Similar results were obtained using HEK 293 cells which lack endogenous K+ channel subunits. These effects did not occur when Kv1.5 was coexpressed with either Kvbeta1.2 or Kvbeta1.3 lacking the amino terminus, suggesting involvement of this region of Kvbeta1.3. Removal of a consensus PKA phosphorylation site on the Kvbeta1.3 NH2 terminus (serine 24), but not alternative sites in either Kvbeta1.3 or Kv1.5, resulted in loss of the functional effects of kinase activation. The effects of phosphorylation appeared to be electrostatic, as replacement of serine 24 with a negatively charged amino acid reduced beta-mediated inactivation, while substitution with a positively charged residue enhanced it. These results indicate that Kvbeta1.3-induced inactivation is reduced by PKA activation, and that phosphorylation of serine 24 in the subunit NH2 terminus is responsible.
0 Communities
1 Members
0 Resources
17 MeSH Terms